InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-42.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Fonteyne Paul R., Director. Officer active across 5 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 11 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €165k. Activity tracked since 10 August 2021. The latest transaction was disclosed on 1 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Fonteyne Paul R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
30,666 sharesCommon StockSEC:0001193125-26-224618:0
7,961 shares0Common StockSEC:0001492422-26-000010:0
6,267 shares0Common StockSEC:0001127602-25-000425:0
3,341 shares0Common StockSEC:0001127602-24-000120:0
3,867 shares0Common StockSEC:0000899243-23-000668:0
13,275 shares0Common StockSEC:0001752836-22-000143:0
8,275 shares0Common StockSEC:0001752836-22-000098:0
53,832 sharesCommon StockSEC:0001104659-22-057532:0
3,947 shares@ US$19.000.0045% mcap50.0% of flowCommon StockSEC:0000899243-22-001527:0
Canonical exit: 6 Apr 2022 (T+90)
4,230 shares0Common StockSEC:0001127602-22-000726:0
5,000 shares@ US$23.24100.0% of flowCommon StockSEC:0001752836-21-000236:0
Canonical exit: 8 Nov 2021 (T+90)
11 of 11 declarations
About Fonteyne Paul R.
Paul R. Fonteyne is a Director of Apellis Pharmaceuticals, Inc. and COVETRUS, INC. He plays a key role in the governance of these companies and in strategic decision-making.
